LTE4 [Ligand Id: 3352] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL509456
  • GPR17 in Mouse [GtoPdb: 88] [UniProtKB: Q6NS65]
There should be some charts here, you may need to enable JavaScript!
  • CysLT1 receptor in Human [GtoPdb: 269] [UniProtKB: Q9Y271]
There should be some charts here, you may need to enable JavaScript!
  • CysLT2 receptor in Human [GtoPdb: 270] [UniProtKB: Q9NS75]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
GPR17 in Mouse [GtoPdb: 88] [UniProtKB: Q6NS65]
GtoPdb - - 9.51 pEC50 0.31 nM EC50 PLoS ONE (2008) 3: e3579 [PMID:18974869]
CysLT1 receptor in Human [GtoPdb: 269] [UniProtKB: Q9Y271]
GtoPdb - - 7.8 pKi - - - Mol Pharmacol (1998) 53: 750-8 [PMID:9547367]
GtoPdb - - 6.97 pIC50 107 nM IC50 Nature (1999) 399: 789-93 [PMID:10391245]
GtoPdb - - 6.41 pEC50 391 nM EC50 Mol Pharmacol (2011) 79: 270-8 [PMID:21078884]
GtoPdb - - 6.67 pEC50 212 nM EC50 Nature (1999) 399: 789-93 [PMID:10391245]
GtoPdb - - 7.24 pEC50 58 nM EC50 Mol Pharmacol (1999) 56: 657-63 [PMID:10462554];
Biochem Biophys Res Commun (2000) 274: 316-22 [PMID:10913337];
Mol Pharmacol (2000) 58: 1601-8 [PMID:11093801]
CysLT2 receptor in Human [GtoPdb: 270] [UniProtKB: Q9NS75]
GtoPdb - - 6.5 pKi - - - Mol Pharmacol (1998) 53: 750-8 [PMID:9547367]
GtoPdb - - 5.72 pIC50 1890 nM IC50 Biochem Biophys Res Commun (2000) 274: 316-22 [PMID:10913337]
GtoPdb - - 6.16 pIC50 693 nM IC50 J Biol Chem (2000) 275: 30531-6 [PMID:10851239];
Mol Pharmacol (2000) 58: 1601-8 [PMID:11093801]
GtoPdb - - 5.92 pEC50 1208 nM EC50 J Biol Chem (2000) 275: 30531-6 [PMID:10851239];
Mol Pharmacol (2011) 79: 270-8 [PMID:21078884]
GtoPdb - - 7.11 pEC50 77 nM EC50 Biochem Biophys Res Commun (2000) 274: 316-22 [PMID:10913337];
Mol Pharmacol (2000) 58: 1601-8 [PMID:11093801]

ChEMBL data shown on this page come from version 36:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]